Trials / Completed
CompletedNCT03897387
Post Market, Retrospective Study to Evaluate Patients Implanted With Medacta Versafit Cup DM ™️ 2 Years Post-op
A Post-market, Multi-center, Retrospective Study to Identify Clinical Outcomes and Complications Data From Patients Implanted With the Medacta Versafit Cup DM Prosthesis Who Are at Least Two Years Post Surgery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 316 (actual)
- Sponsor
- Medacta USA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a post-market, retrospective with one prospective visit, multi- center study, designed to assess the clinical outcomes, surgical details including Anterior or Posterior surgical approach, and collect all complication data of Medacta Versafit Cup DM used for primary or revision total hip arthroplasty at minimum two year post- operatively.
Conditions
Timeline
- Start date
- 2017-03-01
- Primary completion
- 2022-03-30
- Completion
- 2022-03-30
- First posted
- 2019-04-01
- Last updated
- 2022-04-01
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03897387. Inclusion in this directory is not an endorsement.